vs
维珍大西洋航空（ATLN）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
维珍大西洋航空的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$120.0M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -7.3%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-8.2M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 9.2%）
维珍大西洋航空（简称维珍航空）是英国知名航空公司，总部位于英格兰西萨塞克斯郡克劳利。该公司成立于1984年，最初名为不列颠大西洋航空，创始人原本计划开通伦敦至福克兰群岛的航线，更名后创始人之一将股份售予理查德·布兰森，如今是英国航空市场的核心运营商之一。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ATLN vs PBYI — 直观对比
营收规模更大
ATLN
是对方的1.6倍
$75.5M
营收增速更快
PBYI
高出35.1%
-7.3%
自由现金流更多
PBYI
多$22.6M
$-8.2M
两年增速更快
PBYI
近两年复合增速
9.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $120.0M | $75.5M |
| 净利润 | $-27.1M | — |
| 毛利率 | 9.1% | 69.3% |
| 营业利润率 | -19.5% | 22.7% |
| 净利率 | -22.6% | — |
| 营收同比 | -7.3% | 27.7% |
| 净利润同比 | 60.5% | — |
| 每股收益（稀释后） | $-0.48 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATLNPBYI
| Q4 25 | $120.0M | $75.5M | ||
| Q3 25 | $110.1M | $54.5M | ||
| Q2 25 | $102.9M | $52.4M | ||
| Q1 25 | $102.8M | $46.0M | ||
| Q4 24 | $129.5M | $59.1M | ||
| Q3 24 | $107.8M | $80.5M | ||
| Q2 24 | $104.6M | $47.1M | ||
| Q1 24 | $100.6M | $43.8M |
净利润ATLNPBYI
| Q4 25 | $-27.1M | — | ||
| Q3 25 | $-10.8M | $8.8M | ||
| Q2 25 | $-10.7M | $5.9M | ||
| Q1 25 | $-10.7M | $3.0M | ||
| Q4 24 | $-68.7M | — | ||
| Q3 24 | $-7.0M | $20.3M | ||
| Q2 24 | $-54.9M | $-4.5M | ||
| Q1 24 | $-4.9M | $-4.8M |
毛利率ATLNPBYI
| Q4 25 | 9.1% | 69.3% | ||
| Q3 25 | 11.3% | 77.7% | ||
| Q2 25 | 11.1% | 76.5% | ||
| Q1 25 | 10.9% | 77.1% | ||
| Q4 24 | 10.3% | 76.4% | ||
| Q3 24 | 11.0% | 63.9% | ||
| Q2 24 | 11.0% | 77.4% | ||
| Q1 24 | 10.4% | 75.5% |
营业利润率ATLNPBYI
| Q4 25 | -19.5% | 22.7% | ||
| Q3 25 | -7.9% | 17.6% | ||
| Q2 25 | -8.4% | 12.7% | ||
| Q1 25 | -9.2% | 8.7% | ||
| Q4 24 | -4.5% | 22.6% | ||
| Q3 24 | -6.0% | 27.4% | ||
| Q2 24 | -7.9% | -4.6% | ||
| Q1 24 | -1.1% | -5.3% |
净利率ATLNPBYI
| Q4 25 | -22.6% | — | ||
| Q3 25 | -9.8% | 16.2% | ||
| Q2 25 | -10.4% | 11.2% | ||
| Q1 25 | -10.5% | 6.5% | ||
| Q4 24 | -53.0% | — | ||
| Q3 24 | -6.5% | 25.2% | ||
| Q2 24 | -52.5% | -9.6% | ||
| Q1 24 | -4.8% | -11.0% |
每股收益（稀释后）ATLNPBYI
| Q4 25 | $-0.48 | $0.26 | ||
| Q3 25 | $-0.20 | $0.17 | ||
| Q2 25 | $-0.20 | $0.12 | ||
| Q1 25 | $-0.20 | $0.06 | ||
| Q4 24 | $-1.37 | $0.40 | ||
| Q3 24 | $-0.16 | $0.41 | ||
| Q2 24 | $-1.96 | $-0.09 | ||
| Q1 24 | $-0.19 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $81.1K | $97.5M |
| 总债务越低越好 | $84.7M | $22.7M |
| 股东权益账面价值 | $-32.1M | $130.3M |
| 总资产 | $113.2M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ATLNPBYI
| Q4 25 | $81.1K | $97.5M | ||
| Q3 25 | $83.4K | $94.4M | ||
| Q2 25 | $374.7K | $96.0M | ||
| Q1 25 | $1.5M | $93.2M | ||
| Q4 24 | $678.7K | $101.0M | ||
| Q3 24 | $1.4M | $96.7M | ||
| Q2 24 | $439.5K | $96.8M | ||
| Q1 24 | $1.7M | $107.2M |
总债务ATLNPBYI
| Q4 25 | $84.7M | $22.7M | ||
| Q3 25 | $76.4M | $34.0M | ||
| Q2 25 | $75.4M | $45.3M | ||
| Q1 25 | $66.9M | $56.7M | ||
| Q4 24 | $80.6M | $68.0M | ||
| Q3 24 | $80.8M | $79.3M | ||
| Q2 24 | $78.5M | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益ATLNPBYI
| Q4 25 | $-32.1M | $130.3M | ||
| Q3 25 | $-22.1M | $115.3M | ||
| Q2 25 | $-18.5M | $104.7M | ||
| Q1 25 | $-14.0M | $97.1M | ||
| Q4 24 | $-12.0M | $92.1M | ||
| Q3 24 | $16.2M | $71.1M | ||
| Q2 24 | $23.0M | $48.5M | ||
| Q1 24 | $16.8M | $51.0M |
总资产ATLNPBYI
| Q4 25 | $113.2M | $216.3M | ||
| Q3 25 | $110.3M | $202.9M | ||
| Q2 25 | $106.8M | $194.9M | ||
| Q1 25 | $106.5M | $196.2M | ||
| Q4 24 | $119.8M | $213.3M | ||
| Q3 24 | $135.6M | $220.7M | ||
| Q2 24 | $134.2M | $205.0M | ||
| Q1 24 | $3.4M | $214.1M |
负债/权益比ATLNPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | 4.98× | 1.12× | ||
| Q2 24 | 3.41× | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.2M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-8.2M | $14.4M |
| 自由现金流率自由现金流/营收 | -6.8% | 19.1% |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-4.5M | $41.7M |
8季度趋势，按日历期对齐
经营现金流ATLNPBYI
| Q4 25 | $-8.2M | $14.4M | ||
| Q3 25 | $-1.3M | $9.7M | ||
| Q2 25 | $-9.5M | $14.1M | ||
| Q1 25 | $14.6M | $3.6M | ||
| Q4 24 | $-426.3K | $15.6M | ||
| Q3 24 | $-1.3M | $11.0M | ||
| Q2 24 | $-15.5M | $1.0M | ||
| Q1 24 | $11.2M | $11.2M |
自由现金流ATLNPBYI
| Q4 25 | $-8.2M | $14.4M | ||
| Q3 25 | $-1.3M | $9.7M | ||
| Q2 25 | $-9.5M | $14.1M | ||
| Q1 25 | $14.6M | $3.6M | ||
| Q4 24 | $-449.4K | $15.6M | ||
| Q3 24 | $-1.4M | $11.0M | ||
| Q2 24 | $-15.5M | $1.0M | ||
| Q1 24 | $11.2M | — |
自由现金流率ATLNPBYI
| Q4 25 | -6.8% | 19.1% | ||
| Q3 25 | -1.2% | 17.7% | ||
| Q2 25 | -9.3% | 26.8% | ||
| Q1 25 | 14.2% | 7.7% | ||
| Q4 24 | -0.3% | 26.4% | ||
| Q3 24 | -1.3% | 13.7% | ||
| Q2 24 | -14.8% | 2.1% | ||
| Q1 24 | 11.2% | — |
资本支出强度ATLNPBYI
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
现金转化率ATLNPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
